Robert G Hart1, Lesly A Pearce2, Majid F Bakheet3, Oscar R Benavente4, Robin A Conwit5, Leslie A McClure6, Robert L Talbert7, David C Anderson8. 1. Department of Medicine (Neurology), McMaster University, Hamilton, Ontario, Canada. Electronic address: robert.hart@phri.ca. 2. Biostatistics Consultant, Minot, North Dakota. 3. Department of Neurology, Taiba University, Medina, Saudi Arabia. 4. Department of Neurology, University of British Columbia, Vancouver, British Columbia, Canada. 5. National Institute of Neurological Disorders and Stroke, Rockville, Maryland. 6. Department of Biostatistics, University of Alabama at Birmingham, Birmingham, Alabama. 7. Department of Clinical Pharmacy, University of Texas, Austin, Texas. 8. Department of Neurology, University of Minnesota, Minneapolis, Minnesota.
Abstract
BACKGROUND: Among participants in the Secondary Prevention of Small Subcortical Strokes randomized trial, we sought to identify patients with high versus low rates of recurrent ischemic stroke and to assess effects of aggressive blood pressure control and dual antiplatelet therapy according to risk status. METHODS: Multivariable analyses of 3020 participants with recent magnetic resonance imaging-defined lacunar strokes followed for a mean of 3.7 years with 243 recurrent ischemic strokes. RESULTS: Prior symptomatic lacunar stroke or transient ischemic attack (TIA) (hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.6, 2.9), diabetes (HR 2.0, 95% CI 1.5, 2.5), black race (HR 1.7, 95% CI 1.3, 2.3), and male sex (HR 1.5, 95% CI 1.1, 1.9) were each independently predictive of recurrent ischemic stroke. Recurrent ischemic stroke occurred at a rate of 4.3% per year (95% CI 3.4, 5.5) in patients with prior symptomatic lacunar stroke or TIA (15% of the cohort), 3.1% per year (95% CI 2.6, 3.9) in those with more than 1 of the other 3 risk factors (27% of the cohort), and 1.3% per year (95% CI 1.0, 1.7) in those with 0-1 risk factors (58% of the cohort). There were no significant interactions between treatment effects and stroke risk status. CONCLUSIONS: In this large, carefully followed cohort of patients with recent lacunar stroke and aggressive blood pressure management, prior symptomatic lacunar ischemia, diabetes, black race, and male sex independently predicted ischemic stroke recurrence. The effects of blood pressure targets and dual antiplatelet therapy were similar across the spectrum of independent risk factors and recurrence risk.
RCT Entities:
BACKGROUND: Among participants in the Secondary Prevention of Small Subcortical Strokes randomized trial, we sought to identify patients with high versus low rates of recurrent ischemic stroke and to assess effects of aggressive blood pressure control and dual antiplatelet therapy according to risk status. METHODS: Multivariable analyses of 3020 participants with recent magnetic resonance imaging-defined lacunar strokes followed for a mean of 3.7 years with 243 recurrent ischemic strokes. RESULTS: Prior symptomatic lacunar stroke or transient ischemic attack (TIA) (hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.6, 2.9), diabetes (HR 2.0, 95% CI 1.5, 2.5), black race (HR 1.7, 95% CI 1.3, 2.3), and male sex (HR 1.5, 95% CI 1.1, 1.9) were each independently predictive of recurrent ischemic stroke. Recurrent ischemic stroke occurred at a rate of 4.3% per year (95% CI 3.4, 5.5) in patients with prior symptomatic lacunar stroke or TIA (15% of the cohort), 3.1% per year (95% CI 2.6, 3.9) in those with more than 1 of the other 3 risk factors (27% of the cohort), and 1.3% per year (95% CI 1.0, 1.7) in those with 0-1 risk factors (58% of the cohort). There were no significant interactions between treatment effects and stroke risk status. CONCLUSIONS: In this large, carefully followed cohort of patients with recent lacunar stroke and aggressive blood pressure management, prior symptomatic lacunar ischemia, diabetes, black race, and male sex independently predicted ischemic stroke recurrence. The effects of blood pressure targets and dual antiplatelet therapy were similar across the spectrum of independent risk factors and recurrence risk.
Authors: Oscar R Benavente; Robert G Hart; Leslie A McClure; Jeffrey M Szychowski; Christopher S Coffey; Lesly A Pearce Journal: N Engl J Med Date: 2012-08-30 Impact factor: 91.245
Authors: Vincent C T Mok; Alexander Y L Lau; Adrian Wong; Wynnie W M Lam; Anne Chan; Howan Leung; Edward Wong; Yannie Soo; Thomas Leung; Lawrence K S Wong Journal: Int J Stroke Date: 2009-04 Impact factor: 5.266
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Thalia S Field; Lesly A Pearce; Richard W Asinger; Nathan G Chan Smyth; Sabe K De; Robert G Hart; Oscar R Benavente Journal: J Stroke Cerebrovasc Dis Date: 2015-04-01 Impact factor: 2.136
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Ashkan Shoamanesh; Lesly A Pearce; Carlos Bazan; Luciana Catanese; Leslie A McClure; Mukul Sharma; Joan Marti-Fabregas; David C Anderson; Carlos S Kase; Robert G Hart; Oscar R Benavente Journal: Ann Neurol Date: 2017-07-19 Impact factor: 10.422
Authors: Negar Asdaghi; Lesly A Pearce; Makoto Nakajima; Thalia S Field; Carlos Bazan; Franco Cermeno; Leslie A McClure; David C Anderson; Robert G Hart; Oscar R Benavente Journal: Stroke Date: 2014-09-04 Impact factor: 7.914
Authors: Shadi Yaghi; Ava L Liberman; Nils Henninger; Brian Mac Grory; Amre Nouh; Erica Scher; James Giles; Angela Liu; Muhammad Nagy; Ashutosh Kaushal; Idrees Azher; Hiba Fakhri; Kiersten Brown Espaillat; Syed Daniyal Asad; Hemanth Pasupuleti; Heather Martin; Jose Tan; Manivannan Veerasamy; Charles Esenwa; Natalie Cheng; Khadean Moncrieffe; Iman Moeini-Naghani; Mithilesh Siddu; Tushar Trivedi; Koto Ishida; Jennifer Frontera; Aaron Lord; Karen Furie; Salah Keyrouz; Adam de Havenon; Eva Mistry; Christopher R Leon Guerrero; Muhib Khan Journal: J Stroke Cerebrovasc Dis Date: 2020-05-13 Impact factor: 2.136
Authors: Thalia S Field; Fergus N Doubal; Wendy Johnson; Ellen Backhouse; Caroline McHutchison; Simon Cox; Janie Corley; Alison Pattie; Alan J Gow; Susan Shenkin; Vera Cvoro; Zoe Morris; Julie Staals; Mark Bastin; Ian J Deary; Joanna M Wardlaw Journal: Aging (Albany NY) Date: 2016-09-19 Impact factor: 5.682
Authors: Manuela Mengozzi; Frances A Kirkham; Esme E R Girdwood; Eva Bunting; Erin Drazich; Jean Timeyin; Pietro Ghezzi; Chakravarthi Rajkumar Journal: Front Immunol Date: 2020-07-07 Impact factor: 7.561